Articles tagged with "Approval"

Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab

December 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab

October 17, 2017 • By Mary Beth Nierengarten

Abatacept Approved for Psoriatic Arthritis in Adults; Sirukumab Approval Stalls

September 17, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More

August 13, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Uncertain Future for Romosozumab, Plus FDA Approves Tocilizumab for GCA

July 20, 2017 • By Michele B. Kaufman, PharmD, BCGP

FDA Responds to New Drug Application for Baricitinib

June 15, 2017 • By Michele B. Kaufman, PharmD, BCGP

FDA Drug Labeling, Approval Process Help Minimize Lawsuits Against Pharmaceutical Companies

April 17, 2017 • By Bruce N. Cronstein, MD

Rheumatology Drug Updates: Efficacy & Safety of Guselkumab, Plus FX006 for Knee OA

February 16, 2017 • By Kelly April Tyrrell

Rheumatology Drug Updates: Giant Cell Arteritis Relapse Possible if Tocilizumab Discontinued; Plus Updates on Rituximab, Etanercept

January 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Abaloparatide Promising for Osteoporosis, Plus Secukinumab for Ankylosing Spondylitis

October 10, 2016 • By Michele B. Kaufman, PharmD, BCGP